Lipolytic Peptides for Fat Loss, Explained
By Charles Kamen, MD, board-certified neurologist
AOD-9604 is a peptide fragment used primarily for its potential fat-loss effects. Dr. Charles Kamen, MD, board-certified neurologist at LiveNow Longevity in Las Vegas, offers lipolytic peptides as part of comprehensive weight management protocols. Individual results vary.
What Is AOD-9604?
AOD-9604 is a fragment of human growth hormone (hGH), specifically amino acids 176-191. This portion of the growth hormone molecule is responsible for its fat-burning activity, separate from growth-promoting effects. [1]
The peptide was originally developed for obesity treatment and has been studied for its effects on lipid metabolism.
Mechanism of Action
lipolytic peptides stimulates lipolysis — the breakdown of stored fat — and inhibits lipogenesis — the creation of new fat cells. It appears to work through the same receptor mechanisms as growth hormone but without the growth-promoting effects. [2]
This selectivity theoretically provides fat-loss benefits without the concerns associated with growth hormone use.
Research Evidence
lipolytic peptides havebeen studied in several clinical trials. Early research showed promise for fat mass reduction in obese subjects. However, the evidence base is not as extensive as for other weight-loss medications. [3]
Dr. Kamen discusses the evidence limitations with patients considering lipolytic peptides therapy.
Comparison to Other Fat-Loss Approaches
lipolytic peptides are often compared to other interventions:
Administration
lipolytic peptides are typically administered via subcutaneous injection. Common protocols involve daily or every-other-day injections for several weeks to months. [4] Dr. Kamen establishes treatment protocols based on individual goals and response to therapy.
Key Takeaways
- AOD-9604 is a growth hormone fragment (amino acids 176-191)
- Stimulates lipolysis and inhibits fat creation
- May support fat loss when combined with diet and exercise
- Evidence base is less extensive than weight-loss medications
- Administered via subcutaneous injection
- Dr. Kamen uses lipolytic peptides as part of comprehensive weight management protocols
Common Questions
Is lipolytic peptides the same as growth hormone?
No. AOD-9604 is a fragment (portion) of growth hormone that specifically mediates fat-burning, without the growth-promoting effects. It is sometimes called "fractionated GH."
Does lipolytic peptides work for weight loss?
Research shows some fat-loss benefit, but the evidence is not as robust as for weight-loss medications like dual-hormone agonists. Dr. Kamen discusses realistic expectations.
What are the side effects of lipolytic peptides?
Reported side effects are generally mild and may include injection site reactions, headache, and fatigue. Long-term safety data is limited.
Can lipolytic peptides be stacked with other peptides?
Yes. lipolytic peptides are sometimes combined with other peptides like growth hormone secretagogues/growth hormone secretagogues for enhanced body composition effects. Dr. Kamen develops safe stacking protocols.
How long should I use lipolytic peptides?
Treatment duration varies. Dr. Kamen establishes protocols and monitors response throughout therapy.
Will lipolytic peptides cause me to lose muscle?
Unlike growth hormone, lipolytic peptides are not associated with muscle growth. Any muscle effects would likely be neutral. Adequate protein intake and exercise are important during therapy.
lipolytic peptides may support fat loss as part of a comprehensive weight management protocol. Discuss lipolytic peptides with Dr. Kamen to determine whether it fits your treatment plan.
References
- Ng FM, Sun J, Sharma L, et al. Horm Res. 2000;53(6):274-278. (Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone).
- Heffernan M, Summers RJ, Thorburn A, et al. Endocrinology. 2001;142(12):5182-5189. (Effects of human GH and its lipolytic fragment AOD9604 on lipid metabolism).
- Renke G, Chinellato L. Int J Mol Sci. 2026;27(9). (Therapeutic peptides in aesthetic, metabolic and endocrine conditions: effects, safety, and clinical evidence).
- Renke G, Chinellato L. Int J Mol Sci. 2026;27(9). (Therapeutic peptides in metabolic and endocrine conditions: administration and clinical considerations).
Wondering what’s right for you?
Get a straight answer from board-certified neurologist Dr. Charles Kamen, MD. The evaluation is $88 and is applied toward your protocol if you continue care.